Preoperative systemic levels of VEGFA, IL ‐7, IL‐17A, and TNF‐β delineate two distinct groups of children with brain tumors
ConclusionsWe identify common features and individual differences in the systemic immune profiles of children with brain tumors. Overall, patients with MB displayed a uniform cytokine profile, whereas other tumor diagnoses did not predict systemic immunological status in single patients. Future characterization and monitoring of systemic immune responses in children with brain tumors will have important implications for the development and implementation of immunotherapy.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Emma Sand én, Julio Enríquez Pérez, Edward Visse, Marcel Kool, Helena Carén, Peter Siesjö, Anna Darabi Tags: Research Article Source Type: research
More News: Allergy & Immunology | Astrocytoma | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Child Development | Children | Ependymoma | Glioma | Immunotherapy | Medulloblastoma | Neurology | Pediatrics | Pilocytic Astrocytoma | Sarcomas